文献速递神经免疫

新治疗时代多发性硬化女性妊娠期间复发发生情况

Relapse occurrence in women with multiple sclerosis during pregnancy in the new treatment era.
PubMed 文献 · Neurology · 2018-02-02

该横断面研究基于国家多发性硬化登记系统,纳入99次妊娠(87例复发型多发性硬化患者),妊娠期和产后复发率分别为17.2%和13.7%,复发多发生于妊娠早期(n=6)和晚期(n=7)。孕前使用那他珠单抗和芬戈莫德者复发率最高,较长洗脱期与复发发生显著相关。

要点

  • 妊娠期复发率为17.2%,产后复发率为13.7%,多数复发发生于妊娠早期(n=6)和晚期(n=7)。
  • 孕前使用那他珠单抗和芬戈莫德的患者复发率最高。
  • 较长洗脱期与妊娠期复发发生显著相关。

核心结论

  • 妊娠期复发率高于既往已发表数据。
  • 孕前使用高效疗法且洗脱期较长与妊娠期复发风险增加相关。
  • 产后复发率与既往报告相似。

研究设计与样本

  • 横断面研究,使用国家多发性硬化登记系统识别妊娠的复发型多发性硬化女性。
  • 收集人口学、临床特征及疾病修正治疗(DMT)包括洗脱期的数据,提取复发时间和持续时间。
  • 采用多变量逻辑回归评估复发与既往使用不同DMT的关系。
  • 共99次妊娠(87例患者)数据完整。

主要发现

  • 平均年龄31.8±5岁,平均发病年龄24.4±5.6岁,平均病程7.4±4.6年。
  • 89.9%的妊娠发生于孕前一年使用DMT的患者,平均治疗时长63.4±29个月。
  • 妊娠期复发率为17.2%,产后复发率为13.7%。
  • 多数复发发生于妊娠早期(n=6)和晚期(n=7)。
  • 孕前使用那他珠单抗和芬戈莫德的患者复发率最高,较长洗脱期与复发发生显著相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the rate of relapse occurrence during pregnancy and postpartum. METHODS: In a cross-sectional study using the national multiple sclerosis (MS) registry, pregnant women with relapsing MS were identified. Data on demographics, clinical characteristics, and disease-modifying therapies (DMTs), including washout periods, were collected. Timings and durations of relapses were extracted. A multivariate logistic regression was used to assess the relationship between relapses and prior use of different DMTs. RESULTS: Completed data were available for 99 pregnancies (87 patients). Mean age and mean age at onset were 31.8 ± 5 and 24.4 ± 5.6 years, respectively, while the mean disease duration was 7.4 ± 4.6 years. Most pregnancies (89.9%) occurred in patients who were on DMTs in the year preceding pregnancy with a mean treatment duration of 63.4 ± 29 months. The rates of occurrence of relapses during pregnancy and postpartum were 17.2% and 13.7%, respectively. Most of the relapses occurred during the first (n = 6) and third (n = 7) trimesters. Rate of relapse was highest among patients receiving natalizumab and fingolimod before pregnancy. A longer washout period was significantly associated with relapse occurrence. CONCLUSION: The relapse occurrence during pregnancy is higher than the previously published rates. The use of high-efficacy therapies with long washout periods before conception was associated with an increased risk of relapses during pregnancy. Postpartum relapse occurrence was similar to that in previous reports.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Alroughani R, Alowayesh MS, Ahmed SF, et al. Relapse occurrence in women with multiple sclerosis during pregnancy in the new treatment era. Neurology. 2018. PMID: 29429970. doi:10.1212/WNL.0000000000005065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。